OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Encapsulation of Asparaginase as a Promising Strategy to Improve In Vivo Drug Performance
Francisca Villanueva‐Flores, Andrés Zárate‐Romero, Alfredo G. Torres, et al.
Pharmaceutics (2021) Vol. 13, Iss. 11, pp. 1965-1965
Open Access | Times Cited: 13

Showing 13 citing articles:

Desirable L-asparaginases for treating cancer and current research trends
Kindu Tsegaye, Berhanu Andualem Tsehai, Birhan Getie
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 10

Nanoparticle-mediated metronomic chemotherapy in cancer: A paradigm of precision and persistence
Apoorv Kirti, Faizan Zarreen Simnani, Snehasmita Jena, et al.
Cancer Letters (2024) Vol. 594, pp. 216990-216990
Closed Access | Times Cited: 6

Fucoidan as an Encapsulant material: Applications and advantages in active agents and probiotic encapsulations
Supaluck Kraithong, Atiruj Theppawong, Yonghong Liu, et al.
Food Chemistry (2025) Vol. 477, pp. 143570-143570
Closed Access

Co-encapsulation of l-asparaginase and etoposide in dextran nanoparticles for synergistic effect in chronic myeloid leukemia cells
Matthias Konhäuser, Vinod K. Kannaujiya, Elena Steiert, et al.
International Journal of Pharmaceutics (2022) Vol. 622, pp. 121796-121796
Closed Access | Times Cited: 17

l‐Asparaginase Bio‐Betters: Insight Into Current Formulations, Optimization Strategies and Future Bioengineering Frontiers in Anti‐Cancer Drug Development
Sukanya Sonowal, Kalyani Pathak, Dibyajyoti Das, et al.
Advanced Therapeutics (2024) Vol. 7, Iss. 10
Closed Access | Times Cited: 2

Overview of the structure, side effects, and activity assays of l-asparaginase as a therapy drug of acute lymphoblastic leukemia
Nanxiang Wang, Wenhui Ji, Lan Wang, et al.
RSC Medicinal Chemistry (2022) Vol. 13, Iss. 2, pp. 117-128
Open Access | Times Cited: 11

P22-Based Nanovaccines against Enterohemorrhagic Escherichia coli
Alejandro Huerta‐Saquero, Itziar Chapartegui-González, Sarah Bowser, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 2
Open Access | Times Cited: 6

A Novel Formulation of Asparaginase Encapsulated into Virus-like Particles of Brome Mosaic Virus: In Vitro and In Vivo Evidence
Francisca Villanueva‐Flores, Ana Ruth Pastor, Laura A. Palomares, et al.
Pharmaceutics (2023) Vol. 15, Iss. 9, pp. 2260-2260
Open Access | Times Cited: 4

Microbial L Asparaginases Therapeutic and Industrial Applications
Rupa Acharya, Birendra Kumar Bindhani, Nibha Gupta
Defence Life Science Journal (2024) Vol. 9, Iss. 3, pp. 233-241
Open Access

A Review of the Effectiveness of Using Nanoparticles in the Treatment and Diagnosis of Breast Cancer
Kanchan Kohli, Bharti Mangla, Anzarul Haque, et al.
Clinical Cancer Investigation Journal (2024) Vol. 13, Iss. 2, pp. 16-20
Open Access

The use of L-asparaginase for the treatment of solid tumors: data from experimental studies and clinical trials
I. A. Kislyak, M. V. Pokrovskaya, Darya Yu. Zhanturina, et al.
Russian Journal of Oncology (2023) Vol. 28, Iss. 1, pp. 79-94
Open Access | Times Cited: 1

Conjugation and encapsulation of L-asparaginase: an effective strategy for augmenting enzyme potential for anticancer activity
Ahana Bhaduri, Adrija Bose, Mukesh Singh, et al.
Food Science and Applied Biotechnology (2023) Vol. 6, Iss. 2, pp. 339-339
Open Access

Page 1

Scroll to top